Key Dates
6 May 2008
Notification of Acceptances
26 May 2008
Early Registration Cut-off Date
9 June 2008
Late breaking Abstract Submission Date
2 July 2008
Pre & Post Congress Tours
2 July 2008
Social Program Bookings
2 July 2008
Congress Day Tours
9 July 2008
Accommodation Bookings
9 July 2008
Accommodation Deposit deadline
9-10 August 2008
Postgraduate Weekend Courses
10-14 August 2008
Congress Opens
With thanks to
Dr Rene J. Duquesnoy
Rene J. Duquesnoy was born in the Netherlands where he obtained a graduate degree in chemical engineering from the Technological University of Delft. He received a Ph.D. degree in Pathology from the University of Tennessee in Memphis and did a post-doctoral fellowship with Robert A. Good at the University of Minnesota. After his affiliation with the Medical College of Wisconsin and the Blood Center of Wisconsin, he became a tenured Professor of Pathology, with joint appointments in Immunology and Surgery at the University of Pittsburgh Medical Center.
Dr. Duquesnoy’s research deals with HLA and transplantation immunology. His curriculum vitae has 350 publications and more than 450 scientific presentations at national and international meetings. Milestones include cross-reactive HLA matching in platelet transfusions, the discovery of the MB system (now called HLA-DQ), alloreactivity of graft-infiltrating T-cells, the dualistic role of HLA in liver transplantation, role of stress proteins in transplant immunity, antibody analysis of highly sensitized patients and more recently, a structurally based histocompatibility algorithm called HLAMatchmaker. Downloadable programs and detailed information are available on the website http://tpis.upmc.edu.
Dr. Duquesnoy serves on the editorial board of Transplantation and several other professional journals. He is past president of the American Society of Histocompatibility and Immunogenetics.
Robert A. Montgomery, MD, DPhil
Robert A. Montgomery, MD, DPhil, is an Associate Professor of Surgery, Director of the Incompatible Kidney Transplant Program, Chief of the Division of Transplantation, and Director of the Comprehensive Transplant Center, at the Johns Hopkins University and Hospital. He received his Medical education at the University of Rochester where he was the valedictorian of his class. He received his PhD at the University of Oxford, England in molecular immunology. Montgomery completed his general surgical and multi-organ transplantation training at Johns Hopkins Hospital. He was a postdoctoral fellow in Human Molecular Genetics, also at Johns Hopkins.
Dr. Montgomery has been involved in the development of innovative approaches to expanding live donor renal transplantation including: the laparoscopic donor nephrectomy, positive crossmatch and ABO incompatible transplantation, paired kidney exchange, and altruistic donor programs. His work with patients in these programs has been featured on the Today Show, Good Morning America, The CBS, ABC and NBC Evening News, CNN, The Discovery Channel, and in USA Today, The New York Times, Wall Street Journal, and The Washington Post. He was part of the team that performed the world's first live donor kidney removal using minimally invasive techniques. He led the team that performed the first triple swap kidney transplant and 5-way domino transplant. He is considered a world's expert on kidney transplantation for highly-sensitized and ABO incompatible patients. His other clinical interests include the use of expanded criteria donors and pulsatile perfusion pumping to preserve and rescue these organs. Dr. Montgomery is the principle investigator on a Health and Human Services grant to study methods of optimizing utilization of kidneys from deceased donors. He runs an NIH funded laboratory which is focused on the mechanisms underlying the immunomodulatory effect of plasmapheresis, as well as gene and cell based therapies for ameliorating ischemia/reperfusion injury to transplanted organs.
Dr. Montgomery is a member of many Surgical Societies. He has received important awards and distinctions including a Fulbright Scholarship and a Thomas J. Watson Fellowship and memberships in the Phi Beta Kappa and Alpha Omega Alpha academic honor societies. He has been awarded multiple scholarships from The American College of Surgeons and The American Society of Transplant Surgeons.
Dr Norio Yoshimura, M.D., Ph. D., FACS
Norio Yoshimura, M.D., Ph.D. is a Professor and Chairman of the Department of Organ Transplant and General Surgery, Director of the kidney transplant center at the Kyoto Prefectural University of Medicine and Hospital. He received his medical education and ph.D. at the Kyoto Prefectural University of Medicine. He was a research scientist from 1983 to 1985 at the Department of Surgery, Division of Immunology and Organ transplantation, University of Texas at Houston directed by professor Barry D. Kahan. Ph.D., MD..
Dr. Yoshimura has been involved in the development of new immunosuppressive drug, FTY 720.
He started ABO incompatible kidney transplantation in 1990 and performed over forty patients until now. From 1999 when he has a responsibility to the department of organ transplantation, survival of ABO incompatible graft is 100%. He also has experiences of Tx with positive crossmatch patients.
Dr. Yoshimura is a member of many Surgical Societies, namely The American college of Surgeons, ASTS, ILTS, ESOT, and councilor of The Japanese Surgical Associations and Japan Society for Organ Transplantation.
Return to the State of The Art Program
